Clinical Trial Update: The Effects of Dexmedetomidine Dose on Motor Evoked Potentials [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining how different dexmedetomidine doses affect motor evoked potentials during spinal fusion, results posted after termination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury
• Spinal Fusion
• Spinal Stenosis

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Spinal Fusion | Phase 4 | Status: TERMINATED | Results posted: 2020-04-28